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Recently in Cell, Jia et al. (2012) reported novel Utf1-controlled mechanisms of maintaining pluripotency and
self-renewal in embryonic stem cells (ESCs). Utf1 buffers bivalent gene expression by competitive binding
with polycomb repressive complex 2 and initiation of mRNA degradation.In 1998, Okuda et al. discovered a protein
expressed specifically in two pluripotent
cell lines: mouse embryonic carcinoma
cells (mECs) and mouse embryonic stem
cells (mESCs). Because of its restricted
expression pattern, the protein was
named Undifferentiated Embryonic Cell
Transcription Factor 1 (Utf1) (Okuda
et al., 1998). Utf1 is quickly downregu-
lated in mESCs during differentiation and
the protein is not expressed in somatic
cells. Van den Boom et al. (2007) later
identified Utf1 as a chromatin-associated
factor that is required for proper differen-
tiation of both mECs and mESCs. Now
Jia et al. (2012) have made a significant
advance in our understanding of not
only Utf1 itself, but also the regulatory
machinery controlling ESC pluripotency
and self-renewal, cellular processes in
which Utf1 plays integral roles.
Surprisingly, despite its name invoking
a surmised role as a transcription factor,
the activities of Utf1 in ESCs identified to
date do not appear to involve action as
a classical transcription factor. Jia et al.(2012) found instead that Utf1 contributes
to regulation of pluripotency by acting as
an epigenetic and translational factor. In
the former role, Utf1 fine-tunes the effects
of ESC-specific bivalent domains on gene
expression. Bivalent domains are epige-
netically regulated chromatin regions
that allow key developmental genes to
be poised in preparation for differentia-
tion, while concurrently maintaining low
levels of actual expression in the undiffer-
entiated state (Bernstein et al., 2006).
Bivalent domains are characterized by
a combination of large regions of re-
pressive H3 lysine 27 trimethylation
(H3K27me3) epigenetic marks, and
smaller regions of active H3 lysine 4
trimethylation (H3K4me3) epigenetic
marks. Jia et al. (2012) found that Utf1
contributes to regulation of pluripotency
by fine-tuning the effects of these ESC-
specific bivalent domains, in particular
via H3K27me3 and also by posttranscrip-
tional mRNA pruning.
Using ChIP-Seq tomap global genomic
DNA binding sites of Utf1 in mESCs, Jiaet al. (2012) reported approximately
75,000 chromatin regions bound by Utf1
including a large cohort of genes related
to organ/system development and cell
differentiation. RNA-Seq of Utf1 null
versus control mESCs identified almost
800 genes influenced by Utf1 levels by
at least 1.5-fold. Integrating the genomic
binding and RNA-Seq data sets revealed
that Utf1 directly bound most genes that
exhibited altered expression in ESCs
with Utf1 loss of function. Intriguingly,
the majority of these Utf1 target genes
were both bivalent and targets of poly-
comb repressive complex 2 (PRC2)
including its Suz12 subunit. They further
identified the mechanism of Utf1-medi-
ated gene upregulation, which involves
competing with PRC2 to bind an AG-rich
motif within CpG islands. It was already
known that PRC2 is required for estab-
lishing silenced and poised states of biva-
lent genes in ESCs (reviewed in Zhou
et al., 2011). Jia et al. (2012) propose
a model in which Utf1 prevents excessive
inhibition of bivalent genes by blocking
Figure 1. A Model Showing Opposing Functions of Utf1 on Bivalent
Gene Expression in Pluripotent Stem Cells
Yellow circles labeled ‘‘BiV’’ represent bivalent genes. Other factors are pre-
sented as indicated with Utf1 in blue, Arf in green, and PRC2 in red. mDc is
the mRNA decapping complex. Smaller circles represent mRNAs being
degraded. In the balance, decreased BiV levels are reflected by the scale
pan going up and being less weighty, while the reverse is the case on the right
with increasing BiV levels.
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H3K27me3.
Utf1 also operates on
a second, unexpected level
to buffer bivalency. Jia et al.
(2012) found that Utf1 fine-
tunes bivalent gene expres-
sion by tagging newly
transcribed mRNAs in the
nucleus for cytoplasmic
degradation. Biotin-Utf1 pull-
down of mESC nuclear
extracts identified interac-
tions between Utf1 and three
members of the mRNA de-
capping complex: Dcp1a,
Ddx6, and Edc3. Sequential




Utf1 is necessary to recruit
Dcp1a to bivalent gene
promoter regions. These find-
ings establish an exciting,
new area of research formRNA pruning in ESCs because mRNA
pruning has only been studied previously
in fungi and animal somatic cells (re-
viewed in Ling et al., 2011). Through its
opposing functions of inhibiting PRC2
binding and initiating mRNA degradation
via recruitment and interaction with the
mRNA decapping complex, Utf1 main-
tains a precise level of bivalent gene
expression that is ‘‘just right’’ formaintain-
ing pluripotency of ESC chromatin. In this
sense, Utf1 is the youngest bear from the
Goldilocks tale, ensuring that the condi-
tions are precisely right for maintaining
pluripotency.
Clues as to how Utf1 is involved in the
differentiation process are also sug-
gested by Utf1 loss of function and
changes in bivalent gene expression
levels during ectoderm, mesoderm, and
trophectoderm differentiation. Loss of
Utf1 expression in ectoderm and meso-
endoderm by shRNA results in an
increase in PRC2 binding of key develop-
mental genes Olig2, Nestin, and T as well
as an increase in H3K27me3 at these
promoters. On the other hand, the
expression level of Hoxa1 significantly
increases after loss of Utf1 due to
a decrease in mRNA pruning activity;
Dcp1a knockdown recapitulates this
phenotype. When Utf1 null mESCs aredifferentiated by embryoid-body forma-
tion Olig2, Nestin, T, Hoxa1, and other
important mesoderm development
genes, Gata6 and Bmp4 are misregu-
lated. From extensive in vivo assays of
trophectoderm differentiation and Cdx2
expression, Jia et al. (2012) found that
Utf1 deletion does not block trophecto-
derm differentiation, but rather, disrupts
the connection between the cells’ differ-
entiation and proliferation cycles.
Jia et al. (2012) report that Utf1, in
addition to fine-tuning bivalency to
preserve pluripotency, also maintains
self-renewal in mESCs. Utf1 acts directly
to downregulate the levels of Arf, a known
inhibitor of ESC proliferation, by initiating
Arf mRNA degradation. Arf is also known
to be directly upregulated by Myc in
ESCs. Oct3/4 and Sox2 directly upregu-
late Utf1 transcription (Nishimoto et al.,
1999) and Utf1 in turn translationally
inhibits the Myc-Arf feedback loop within
mESCs. Thus, Utf1 links together key
pathways in ESCs in a novel way. We
highlight the seemingly opposing mecha-
nisms of Utf1 function in mESCs as
observed by Jia et al. (2012) that to-
gether balance bivalent gene expression
(Figure 1).
The indirect connection between Myc
and Utf1 raised by Jia et al. (2012)Cell Stem Cell 11, December 7,suggests possible mecha-
nisms underlying the obser-
vation made in 2008 that re-
placing Myc with Utf1
increases reprogramming
efficiency (relative to Oct4,
Sox2, and Klf4 alone) (Zhao
et al., 2008). One interesting
notion is that in the absence
of exogenous Myc, which
suppresses differentiation-
associated gene expression
(Varlakhanova et al., 2010),
Utf1 switches to suppressing
differentiation-associated
gene expression. However,
the mechanisms by which
Utf1 stimulates reprogram-
ming in the absence of exog-
enous Myc remain unknown.
It is also notable that Utf1 is
an early stage indicator of
successful reprogramming
(Buganim et al., 2012).
A number of important
open questions remain about
Utf1. Does Utf1 have aneffect on global chromatin structure as
suggested by its 75,000 binding sites on
ESC chromatin? Is there a more direct
relationship between Utf1 and Myc?
What specific roles does Utf1 have during
ESC differentiation? How does Utf1
function to enhance cellular reprogram-
ming, and do any of the mechanisms by
which Utf1 functions in ESCs manifest in
iPSCs as well? Does Utf1 function in
some contexts as a transcription factor
as its name implies? Do the functions
outlined for Utf1 in mESCs also manifest
in human ESCs? The Jia et al. (2012)
paper also raises exciting broader ques-
tions about the potential role of mRNA
decapping in cellular reprogramming.
Future studies tackling these questions,
in part inspired by these recent studies
of Utf1, will greatly advance our
understanding of self-renewal and
pluripotency.REFERENCES
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